Intrinsic value of Rite Aid - RAD

Previous Close

$1.86

  Intrinsic Value

$2.82

stock screener

  Rating & Target

str. buy

+51%

  Value-price divergence*

+60%

Previous close

$1.86

 
Intrinsic value

$2.82

 
Up/down potential

+51%

 
Rating

str. buy

 
Value-price divergence*

+60%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of RAD stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.0

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2017(a)
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  6.86
  6.90
  6.71
  6.54
  6.39
  6.25
  6.12
  6.01
  5.91
  5.82
  5.74
  5.66
  5.60
  5.54
  5.48
  5.43
  5.39
  5.35
  5.32
  5.29
  5.26
  5.23
  5.21
  5.19
  5.17
  5.15
  5.14
  5.12
  5.11
  5.10
  5.09
Revenue, $m
  32,845
  35,111
  37,467
  39,917
  42,466
  45,119
  47,881
  50,758
  53,758
  56,885
  60,148
  63,554
  67,111
  70,826
  74,710
  78,770
  83,016
  87,460
  92,110
  96,978
  102,076
  107,415
  113,009
  118,871
  125,015
  131,455
  138,207
  145,287
  152,712
  160,500
  168,668
Variable operating expenses, $m
 
  34,257
  36,544
  38,922
  41,397
  43,972
  46,653
  49,447
  52,358
  55,394
  58,562
  61,697
  65,150
  68,757
  72,526
  76,468
  80,591
  84,904
  89,418
  94,144
  99,093
  104,276
  109,707
  115,398
  121,362
  127,614
  134,169
  141,042
  148,250
  155,809
  163,739
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  32,369
  34,257
  36,544
  38,922
  41,397
  43,972
  46,653
  49,447
  52,358
  55,394
  58,562
  61,697
  65,150
  68,757
  72,526
  76,468
  80,591
  84,904
  89,418
  94,144
  99,093
  104,276
  109,707
  115,398
  121,362
  127,614
  134,169
  141,042
  148,250
  155,809
  163,739
Operating income, $m
  476
  855
  923
  995
  1,069
  1,147
  1,228
  1,312
  1,399
  1,491
  1,586
  1,857
  1,961
  2,070
  2,183
  2,302
  2,426
  2,556
  2,692
  2,834
  2,983
  3,139
  3,302
  3,474
  3,653
  3,841
  4,039
  4,246
  4,462
  4,690
  4,929
EBITDA, $m
  1,044
  1,422
  1,517
  1,617
  1,720
  1,827
  1,939
  2,056
  2,177
  2,304
  2,436
  2,574
  2,718
  2,869
  3,026
  3,190
  3,362
  3,542
  3,730
  3,928
  4,134
  4,350
  4,577
  4,814
  5,063
  5,324
  5,597
  5,884
  6,185
  6,500
  6,831
Interest expense (income), $m
  410
  417
  414
  456
  499
  545
  592
  641
  692
  745
  800
  858
  918
  982
  1,047
  1,116
  1,188
  1,263
  1,342
  1,425
  1,511
  1,601
  1,696
  1,795
  1,899
  2,008
  2,122
  2,242
  2,367
  2,499
  2,637
Earnings before tax, $m
  48
  438
  509
  539
  570
  602
  636
  671
  708
  746
  786
  999
  1,043
  1,088
  1,136
  1,186
  1,238
  1,292
  1,349
  1,409
  1,472
  1,538
  1,606
  1,678
  1,754
  1,833
  1,917
  2,004
  2,095
  2,191
  2,292
Tax expense, $m
  44
  118
  137
  146
  154
  163
  172
  181
  191
  201
  212
  270
  282
  294
  307
  320
  334
  349
  364
  380
  397
  415
  434
  453
  474
  495
  517
  541
  566
  592
  619
Net income, $m
  4
  320
  372
  393
  416
  440
  464
  490
  517
  545
  574
  729
  761
  794
  829
  865
  904
  943
  985
  1,029
  1,074
  1,122
  1,173
  1,225
  1,280
  1,338
  1,399
  1,463
  1,529
  1,600
  1,673

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  245
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  11,594
  12,132
  12,947
  13,793
  14,674
  15,590
  16,545
  17,539
  18,576
  19,656
  20,784
  21,961
  23,190
  24,473
  25,815
  27,218
  28,686
  30,221
  31,828
  33,510
  35,271
  37,117
  39,050
  41,075
  43,198
  45,423
  47,756
  50,203
  52,769
  55,459
  58,282
Adjusted assets (=assets-cash), $m
  11,349
  12,132
  12,947
  13,793
  14,674
  15,590
  16,545
  17,539
  18,576
  19,656
  20,784
  21,961
  23,190
  24,473
  25,815
  27,218
  28,686
  30,221
  31,828
  33,510
  35,271
  37,117
  39,050
  41,075
  43,198
  45,423
  47,756
  50,203
  52,769
  55,459
  58,282
Revenue / Adjusted assets
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
  2.894
Average production assets, $m
  3,174
  3,406
  3,634
  3,872
  4,119
  4,377
  4,644
  4,924
  5,214
  5,518
  5,834
  6,165
  6,510
  6,870
  7,247
  7,641
  8,053
  8,484
  8,935
  9,407
  9,901
  10,419
  10,962
  11,531
  12,126
  12,751
  13,406
  14,093
  14,813
  15,568
  16,361
Working capital, $m
  2,060
  1,966
  2,098
  2,235
  2,378
  2,527
  2,681
  2,842
  3,010
  3,186
  3,368
  3,559
  3,758
  3,966
  4,184
  4,411
  4,649
  4,898
  5,158
  5,431
  5,716
  6,015
  6,329
  6,657
  7,001
  7,361
  7,740
  8,136
  8,552
  8,988
  9,445
Total debt, $m
  7,329
  7,268
  8,001
  8,763
  9,555
  10,380
  11,239
  12,134
  13,067
  14,040
  15,054
  16,114
  17,220
  18,375
  19,583
  20,845
  22,166
  23,548
  24,994
  26,508
  28,093
  29,754
  31,494
  33,317
  35,227
  37,230
  39,330
  41,532
  43,841
  46,262
  48,803
Total liabilities, $m
  10,980
  10,919
  11,652
  12,414
  13,206
  14,031
  14,890
  15,785
  16,718
  17,691
  18,705
  19,765
  20,871
  22,026
  23,234
  24,496
  25,817
  27,199
  28,645
  30,159
  31,744
  33,405
  35,145
  36,968
  38,878
  40,881
  42,981
  45,183
  47,492
  49,913
  52,454
Total equity, $m
  614
  1,213
  1,295
  1,379
  1,467
  1,559
  1,654
  1,754
  1,858
  1,966
  2,078
  2,196
  2,319
  2,447
  2,582
  2,722
  2,869
  3,022
  3,183
  3,351
  3,527
  3,712
  3,905
  4,108
  4,320
  4,542
  4,776
  5,020
  5,277
  5,546
  5,828
Total liabilities and equity, $m
  11,594
  12,132
  12,947
  13,793
  14,673
  15,590
  16,544
  17,539
  18,576
  19,657
  20,783
  21,961
  23,190
  24,473
  25,816
  27,218
  28,686
  30,221
  31,828
  33,510
  35,271
  37,117
  39,050
  41,076
  43,198
  45,423
  47,757
  50,203
  52,769
  55,459
  58,282
Debt-to-equity ratio
  11.936
  5.990
  6.180
  6.350
  6.510
  6.660
  6.790
  6.920
  7.030
  7.140
  7.240
  7.340
  7.430
  7.510
  7.590
  7.660
  7.730
  7.790
  7.850
  7.910
  7.960
  8.020
  8.070
  8.110
  8.150
  8.200
  8.240
  8.270
  8.310
  8.340
  8.370
Adjusted equity ratio
  0.033
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  4
  320
  372
  393
  416
  440
  464
  490
  517
  545
  574
  729
  761
  794
  829
  865
  904
  943
  985
  1,029
  1,074
  1,122
  1,173
  1,225
  1,280
  1,338
  1,399
  1,463
  1,529
  1,600
  1,673
Depreciation, amort., depletion, $m
  568
  568
  594
  622
  650
  680
  712
  744
  778
  813
  850
  717
  757
  799
  843
  888
  936
  986
  1,039
  1,094
  1,151
  1,212
  1,275
  1,341
  1,410
  1,483
  1,559
  1,639
  1,722
  1,810
  1,902
Funds from operations, $m
  -223
  887
  966
  1,015
  1,067
  1,120
  1,176
  1,234
  1,294
  1,358
  1,424
  1,446
  1,518
  1,593
  1,672
  1,754
  1,840
  1,930
  2,024
  2,123
  2,226
  2,334
  2,447
  2,566
  2,691
  2,821
  2,958
  3,101
  3,252
  3,410
  3,575
Change in working capital, $m
  -449
  127
  132
  137
  143
  149
  155
  161
  168
  175
  183
  191
  199
  208
  217
  227
  238
  249
  260
  273
  285
  299
  313
  328
  344
  361
  378
  396
  416
  436
  457
Cash from operations, $m
  226
  760
  834
  878
  924
  972
  1,021
  1,073
  1,127
  1,183
  1,241
  1,255
  1,319
  1,385
  1,454
  1,527
  1,602
  1,681
  1,764
  1,850
  1,940
  2,035
  2,134
  2,238
  2,346
  2,460
  2,580
  2,705
  2,836
  2,974
  3,118
Maintenance CAPEX, $m
  0
  -369
  -396
  -423
  -450
  -479
  -509
  -540
  -573
  -606
  -642
  -678
  -717
  -757
  -799
  -843
  -888
  -936
  -986
  -1,039
  -1,094
  -1,151
  -1,212
  -1,275
  -1,341
  -1,410
  -1,483
  -1,559
  -1,639
  -1,722
  -1,810
New CAPEX, $m
  -481
  -232
  -229
  -238
  -247
  -257
  -268
  -279
  -291
  -303
  -317
  -330
  -345
  -360
  -377
  -394
  -412
  -431
  -451
  -472
  -494
  -518
  -543
  -569
  -596
  -625
  -655
  -687
  -720
  -755
  -792
Cash from investing activities, $m
  -464
  -601
  -625
  -661
  -697
  -736
  -777
  -819
  -864
  -909
  -959
  -1,008
  -1,062
  -1,117
  -1,176
  -1,237
  -1,300
  -1,367
  -1,437
  -1,511
  -1,588
  -1,669
  -1,755
  -1,844
  -1,937
  -2,035
  -2,138
  -2,246
  -2,359
  -2,477
  -2,602
Free cash flow, $m
  -238
  159
  209
  218
  226
  235
  244
  254
  263
  273
  283
  247
  257
  268
  279
  290
  302
  314
  326
  339
  352
  366
  380
  395
  410
  426
  442
  459
  477
  496
  515
Issuance/(repayment) of debt, $m
  309
  -40
  733
  762
  793
  825
  859
  895
  933
  973
  1,015
  1,059
  1,106
  1,156
  1,208
  1,263
  1,321
  1,382
  1,446
  1,514
  1,585
  1,661
  1,740
  1,823
  1,911
  2,003
  2,100
  2,202
  2,309
  2,422
  2,540
Issuance/(repurchase) of shares, $m
  7
  504
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  359
  464
  733
  762
  793
  825
  859
  895
  933
  973
  1,015
  1,059
  1,106
  1,156
  1,208
  1,263
  1,321
  1,382
  1,446
  1,514
  1,585
  1,661
  1,740
  1,823
  1,911
  2,003
  2,100
  2,202
  2,309
  2,422
  2,540
Total cash flow (excl. dividends), $m
  121
  623
  942
  980
  1,019
  1,060
  1,103
  1,148
  1,196
  1,245
  1,297
  1,306
  1,363
  1,423
  1,486
  1,553
  1,622
  1,695
  1,772
  1,853
  1,937
  2,026
  2,120
  2,218
  2,320
  2,428
  2,542
  2,661
  2,786
  2,918
  3,056
Retained Cash Flow (-), $m
  -33
  -823
  -81
  -85
  -88
  -92
  -95
  -99
  -104
  -108
  -113
  -118
  -123
  -128
  -134
  -140
  -147
  -154
  -161
  -168
  -176
  -185
  -193
  -203
  -212
  -223
  -233
  -245
  -257
  -269
  -282
Prev. year cash balance distribution, $m
 
  224
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  24
  860
  895
  931
  969
  1,008
  1,049
  1,092
  1,137
  1,185
  1,188
  1,240
  1,295
  1,352
  1,412
  1,476
  1,542
  1,611
  1,685
  1,761
  1,842
  1,926
  2,015
  2,108
  2,206
  2,309
  2,416
  2,530
  2,649
  2,773
Discount rate, %
 
  13.30
  13.97
  14.66
  15.40
  16.17
  16.97
  17.82
  18.71
  19.65
  20.63
  21.66
  22.75
  23.88
  25.08
  26.33
  27.65
  29.03
  30.48
  32.01
  33.61
  35.29
  37.05
  38.91
  40.85
  42.89
  45.04
  47.29
  49.65
  52.14
  54.74
PV of cash for distribution, $m
 
  21
  663
  594
  525
  458
  393
  333
  277
  226
  182
  137
  106
  80
  59
  42
  30
  20
  13
  9
  5
  3
  2
  1
  1
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3
  71.3

Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

FINANCIAL RATIOS  of  Rite Aid (RAD)

Valuation Ratios
P/E Ratio 490
Price to Sales 0.1
Price to Book 3.2
Price to Tangible Book
Price to Cash Flow 8.7
Price to Free Cash Flow -7.7
Growth Rates
Sales Growth Rate 6.9%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -28.2%
Cap. Spend. - 3 Yr. Gr. Rate 2.7%
Financial Strength
Quick Ratio 12
Current Ratio 0
LT Debt to Equity 1190.2%
Total Debt to Equity 1193.6%
Interest Coverage 1
Management Effectiveness
Return On Assets 0.3%
Ret/ On Assets - 3 Yr. Avg. 18.4%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. 16%
Return On Equity 0.7%
Return On Equity - 3 Yr. Avg. -50.9%
Asset Turnover 2.9
Profitability Ratios
Gross Margin 23.7%
Gross Margin - 3 Yr. Avg. 25.9%
EBITDA Margin 3.1%
EBITDA Margin - 3 Yr. Avg. 3.9%
Operating Margin 1.4%
Oper. Margin - 3 Yr. Avg. 2.3%
Pre-Tax Margin 0.1%
Pre-Tax Margin - 3 Yr. Avg. 0.9%
Net Profit Margin 0%
Net Profit Margin - 3 Yr. Avg. 2.8%
Effective Tax Rate 91.7%
Eff/ Tax Rate - 3 Yr. Avg. -87.2%
Payout Ratio 0%

RAD stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the RAD stock intrinsic value calculation we used $32845 million for the last fiscal year's total revenue generated by Rite Aid. The default revenue input number comes from 2017 income statement of Rite Aid. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our RAD stock valuation model: a) initial revenue growth rate of 6.9% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 13.3%, whose default value for RAD is calculated based on our internal credit rating of Rite Aid, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Rite Aid.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of RAD stock the variable cost ratio is equal to 97.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for RAD stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.7% for Rite Aid.

Corporate tax rate of 27% is the nominal tax rate for Rite Aid. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the RAD stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for RAD are equal to 9.7%.

Life of production assets of 8.6 years is the average useful life of capital assets used in Rite Aid operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for RAD is equal to 5.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $614 million for Rite Aid - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 1057.27 million for Rite Aid is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Rite Aid at the current share price and the inputted number of shares is $2.0 billion.

RELATED COMPANIES Price Int.Val. Rating
CVS CVS Health 72.44 305.83  str.buy
PETS PetMed Express 34.31 42.63  buy
SFLY Shutterfly 48.51 47.10  hold
VSI Vitamin Shoppe 5.35 37.47  str.buy

COMPANY NEWS

▶ In the Saga of Rite Aid Corporation, Amazon Plays Godot   [Oct-18-17 11:40AM  InvestorPlace]
▶ Why Rite Aid, Hudbay Minerals, and NovoCure Jumped Today   [Oct-16-17 04:30PM  Motley Fool]
▶ Why Rite Aid, MannKind, and Sears Holdings Slumped Today   [Oct-11-17 05:09PM  Motley Fool]
▶ Walgreens, Rite Aid, CVS Tumble on the Amazon Scare   [Oct-09-17 04:25PM  Market Realist]
▶ Best Buy: CVS Health, Walgreens, or Rite Aid?   [Oct-08-17 08:04AM  Motley Fool]
▶ Why Rite Aid's Shares Crashed 19% in September   [Oct-05-17 07:31PM  Motley Fool]
▶ Rite Aid Stock Has Upside of 24% in the Next 12 Months   [Oct-04-17 10:39AM  Market Realist]
▶ What Drove Rite Aids 2Q17 Revenue Decline?   [07:44AM  Market Realist]
▶ Rite Aids Top Line Fell for 2nd Consecutive Quarter   [Oct-03-17 05:36PM  Market Realist]
▶ Key Takeaways from Rite Aids 2Q17 Results   [03:49PM  Market Realist]
▶ Rite Aid, JC Penney Tumble into Mondays 52-Week Low Club   [Oct-02-17 04:04PM  24/7 Wall St.]
▶ Can Rite Aids C-Suite Shake-Up Be Good News?   [Sep-30-17 10:31AM  Motley Fool]
▶ Amazon Will Next Take Retail Pharmacy: Bernstein   [Sep-29-17 05:07PM  Investopedia]
▶ Rite Aid posts 2Q profit   [Sep-28-17 09:41PM  Associated Press]
▶ What Happened in the Stock Market Today   [05:00PM  Motley Fool]
▶ This $300 Billion Amazon Rumor Just Won't Die   [04:09PM  Investor's Business Daily]
▶ Rite Aid Stock Crashes On Same-Store Decline   [04:03PM  Investor's Business Daily]
▶ LIVE BLOG: Closing Bell Edition   [03:18PM  TheStreet.com]
▶ Earnings Previews: Can Nike (NKE) Regain Its Footing?   [Sep-25-17 11:50PM  Kiplinger]
▶ Consumer Sector: Last Weeks Index Performance   [02:32PM  Market Realist]
▶ [$$] Walgreens-Rite Aid Pact Can Work   [Sep-21-17 10:50AM  Barrons.com]
▶ Rite Aid Tanks on Walgreens Deal: Time to Buy?   [Sep-20-17 06:18PM  Investopedia]
▶ Best Buy and Rite Aid Stocks Break Support   [01:00PM  Investopedia]
▶ A Look at Rite Aids Stock Crash This Year   [09:09AM  Market Realist]
Financial statements of RAD
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.